PL3768274T3 - Kompozycje zawierające połączenie kwasu glikocholowego i kwasu masłowego lub kwasu oleinowego do zastosowania w leczeniu osteoporozy - Google Patents
Kompozycje zawierające połączenie kwasu glikocholowego i kwasu masłowego lub kwasu oleinowego do zastosowania w leczeniu osteoporozyInfo
- Publication number
- PL3768274T3 PL3768274T3 PL19770322.6T PL19770322T PL3768274T3 PL 3768274 T3 PL3768274 T3 PL 3768274T3 PL 19770322 T PL19770322 T PL 19770322T PL 3768274 T3 PL3768274 T3 PL 3768274T3
- Authority
- PL
- Poland
- Prior art keywords
- acid
- osteoporosis
- treatment
- composition
- combination
- Prior art date
Links
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 title 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 title 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 title 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 title 1
- 108010007979 Glycocholic Acid Proteins 0.000 title 1
- RFDAIACWWDREDC-UHFFFAOYSA-N Na salt-Glycocholic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(=O)NCC(O)=O)C)C1(C)C(O)C2 RFDAIACWWDREDC-UHFFFAOYSA-N 0.000 title 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 title 1
- 239000005642 Oleic acid Substances 0.000 title 1
- 208000001132 Osteoporosis Diseases 0.000 title 1
- RFDAIACWWDREDC-FRVQLJSFSA-N glycocholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 RFDAIACWWDREDC-FRVQLJSFSA-N 0.000 title 1
- 229940099347 glycocholic acid Drugs 0.000 title 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 title 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Organic Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE1850304 | 2018-03-19 | ||
| PCT/SE2019/050246 WO2019182501A1 (en) | 2018-03-19 | 2019-03-19 | A composition for use in the treatment of conditions caused by calcium deficiency |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3768274T3 true PL3768274T3 (pl) | 2024-06-17 |
Family
ID=67987480
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL19770322.6T PL3768274T3 (pl) | 2018-03-19 | 2019-03-19 | Kompozycje zawierające połączenie kwasu glikocholowego i kwasu masłowego lub kwasu oleinowego do zastosowania w leczeniu osteoporozy |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US11679124B2 (pl) |
| EP (1) | EP3768274B1 (pl) |
| JP (1) | JP7383626B2 (pl) |
| CN (1) | CN112074274B (pl) |
| AU (1) | AU2019239073A1 (pl) |
| BR (1) | BR112020018980A2 (pl) |
| CA (1) | CA3094162A1 (pl) |
| ES (1) | ES2974199T3 (pl) |
| MX (1) | MX2020009629A (pl) |
| PL (1) | PL3768274T3 (pl) |
| SA (1) | SA520420164B1 (pl) |
| WO (1) | WO2019182501A1 (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115282136B (zh) * | 2022-08-09 | 2023-10-20 | 中南大学 | 丁酸钠在制备预防和/或治疗继发性甲状旁腺功能亢进制剂中的应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS53107408A (en) | 1977-02-28 | 1978-09-19 | Yamanouchi Pharmaceut Co Ltd | Micellar preparation for rectal infusion |
| EP0252004A1 (de) * | 1986-06-26 | 1988-01-07 | Ciba-Geigy Ag | Pharmazeutische Zusammensetzungen für die parenterale Applikation |
| CA2033725C (en) * | 1990-01-24 | 2001-05-29 | Folker Pittrof | Pharmaceutical and cosmetic compositions containing a salt of cholanic acid |
| ITMI20011321A1 (it) | 2001-06-22 | 2002-12-22 | Chiesi Farma Spa | Composizione farmaceutica in forma di microemulsione atta alla somministrazione per via transdermale di apomorfina utile nel trattamento del |
| US20060052305A1 (en) | 2004-05-10 | 2006-03-09 | Nastech Pharmaceutical Company Inc. | Method of treating osteoporosis using intranasal parathyroid hormone |
| US20070292493A1 (en) | 2006-06-15 | 2007-12-20 | Brierre Barbara T | Pharmaceutical composition and method for the transdermal delivery of calcium |
| US9278992B2 (en) | 2007-06-04 | 2016-03-08 | Nihon University | Function-selective vitamin D receptor agonist |
| CA2710525C (en) * | 2007-12-24 | 2017-08-22 | Sun Pharma Advanced Research Company Limited | Nanodispersion |
| SI2343982T1 (sl) | 2008-09-17 | 2017-08-31 | Chiasma Inc. | Farmacevtski sestavki in metode povezane z dostavo |
| US8563053B2 (en) | 2009-10-29 | 2013-10-22 | Shaker A. Mousa | Compositions and methods of natural products in nanoformulations for the prevention and treatment of osteoporosis |
| GB2478849A (en) * | 2010-03-16 | 2011-09-21 | Chiasma Inc | Improved pharmecutical compositions and methods of delivery |
| US11154559B2 (en) | 2011-09-29 | 2021-10-26 | Ethicon Endo-Surgery, Inc. | Methods and compositions of bile acids |
-
2019
- 2019-03-19 PL PL19770322.6T patent/PL3768274T3/pl unknown
- 2019-03-19 ES ES19770322T patent/ES2974199T3/es active Active
- 2019-03-19 JP JP2020549788A patent/JP7383626B2/ja active Active
- 2019-03-19 MX MX2020009629A patent/MX2020009629A/es unknown
- 2019-03-19 WO PCT/SE2019/050246 patent/WO2019182501A1/en unknown
- 2019-03-19 AU AU2019239073A patent/AU2019239073A1/en active Pending
- 2019-03-19 EP EP19770322.6A patent/EP3768274B1/en active Active
- 2019-03-19 CN CN201980026403.4A patent/CN112074274B/zh active Active
- 2019-03-19 US US16/982,529 patent/US11679124B2/en active Active
- 2019-03-19 BR BR112020018980-4A patent/BR112020018980A2/pt unknown
- 2019-03-19 CA CA3094162A patent/CA3094162A1/en active Pending
-
2020
- 2020-09-19 SA SA520420164A patent/SA520420164B1/ar unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA3094162A1 (en) | 2019-09-26 |
| MX2020009629A (es) | 2021-01-08 |
| JP7383626B2 (ja) | 2023-11-20 |
| US20210000864A1 (en) | 2021-01-07 |
| EP3768274B1 (en) | 2023-11-15 |
| EP3768274A1 (en) | 2021-01-27 |
| SA520420164B1 (ar) | 2022-11-08 |
| EP3768274A4 (en) | 2022-01-05 |
| AU2019239073A1 (en) | 2020-11-12 |
| RU2020133327A (ru) | 2022-04-19 |
| ES2974199T3 (es) | 2024-06-26 |
| BR112020018980A2 (pt) | 2020-12-29 |
| CN112074274B (zh) | 2024-03-26 |
| CN112074274A (zh) | 2020-12-11 |
| JP2021517578A (ja) | 2021-07-26 |
| EP3768274C0 (en) | 2023-11-15 |
| US11679124B2 (en) | 2023-06-20 |
| WO2019182501A1 (en) | 2019-09-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL268406A (en) | Preparations and methods for treating hemoglobin diseases | |
| IL282600A (en) | Composition and method for health care | |
| IL275626A (en) | Preparations and methods for surface treatment | |
| IL290348B1 (en) | Compositions and methods for surface treatment | |
| IL280348A (en) | Preparations and methods for surface treatment | |
| ZA202000461B (en) | Composition for use in the prevention and treatment of pathologies of the cardiovascular apparatus | |
| PL3773615T3 (pl) | Płynna kompozycja do stosowania w leczeniu błony śluzowej przewodu ustno-gardłowo-krtaniowo-przełykowego | |
| EP3768274C0 (en) | COMPOSITION CONTAINING A COMBINATION OF GLYCOCHOLIC ACID AND BUTYRIC ACID OR OLEIC ACID, FOR USE IN THE TREATMENT OF OSTEOPOROSIS | |
| ZA202102991B (en) | Silicic acids for use in the treatment of periodontitis | |
| EP3518951C0 (en) | COMPOSITIONS FOR USE IN THE TREATMENT OF OSTEOPOROSIS AND Fractures | |
| GB201918404D0 (en) | Compounds and their use for the treatment of aplha1-antitrypsin deficiency | |
| IL289371A (en) | Methylthioninium for use in the treatment of synaptopathies | |
| IL288307A (en) | Preparations for use in the treatment of insulin deficiency conditions | |
| IL290192A (en) | Nitanin analogs and their use in the treatment of chronic and acute pain | |
| ZA202006886B (en) | R-fadrozole for use in the treatment of aldostonerism | |
| IL276228A (en) | Compounds and preparations for the treatment of pain | |
| EP3749332A4 (en) | COMPOSITIONS AND THEIR USE IN THE TREATMENT OF ENDOMETRIOSIS AND PAIN | |
| EP3758692A4 (en) | COMPOUNDS AND METHODS FOR TREATING PAIN | |
| RS64967B1 (sr) | Kompozicija za upotrebu u prevenciji i/ili lečenju osteoartikularnih bolesti | |
| GB2574944B (en) | Methods and compositions for the treatment of pain and/or inflammation | |
| ZA201902886B (en) | A cosmetic composition for use in the treatment of unwanted fat deposits | |
| AU2018900412A0 (en) | Compositions and their use in the treatment of endometriosis and pain | |
| IL284032A (en) | 3 beta-(benzyloxy)-17 alpha-methyl-paragan-5-en-20-one for use in the treatment of cognitive disorders | |
| GB201908110D0 (en) | Compositions and methods for use in the treatment of cancer-related fatigue | |
| EP3895774C0 (en) | COMPOSITION AND METHOD FOR TREATMENT OF WASTE LIQUIDS |